The rapid and continuous increase in the percentage of VRE carriage in the EU/EEA is a cause for concern.2
Infections and deaths attributable to VRE almost doubled between 2007-2015
The population-weighted mean percentage for VRE increased from 10.5% in 2015 to 17.3% in 2018
High resistance levels have been reported from all regions in Europe2
VRE has a significant impact on patient length of stay, and in turn, hospitalization costs3
The Solution
VRE has become a substantive and growing burden in hospitalised patients, prompting the need for earlier and accurate detection.
Xpert vanA/vanB enables:
Laboratory efficiencies with on-demand workflows requiring minimal hands-on time, 24/
Timely infection control measures to reduce transmission and outbreaks, and enable appropriate use of isolation facilities
The Impact
Fast and accurate PCR testing with Xpert®vanA/vanB greatly improves time to result, allowing healthcare professionals to quickly and appropriately manage patients, reducing transmission and enabling more efficient bed management.4
Optimize Workflow and Patient Management
On-demand STAT testing provides results 24/7
Ease of use and minimal hands-on-time enables more efficient use of staff time